Due to a conflict with the in-service exams, the deadline for submissions has been extended to March 15, 2017.
With the growing emphasis on value in health care, providing evidence of the value of radiation therapy in the treatment of cancer has become a high priority for providers, payers and policy makers. Value
encompasses aspects of both comparative and cost effectiveness, but it can be more broadly defined to include innovative approaches to evaluating the benefits and harms of radiation oncology interventions. Research that examines the comparative value of radiotherapy has the potential to improve cancer outcomes while slowing the growth of health care spending.
The Radiation Oncology Institute (ROI) is sponsoring the publication of a special edition of Advances in Radiation Oncology on the value of radiation therapy to be published in September 2017. All submitted manuscripts will be considered for ROI Publication Awards, and the 10 accepted papers selected as finalists will be published in the themed edition with their article processing fees waived and will be recognized
at ASTRO’s 2017 Annual Meeting in San Diego. One of the finalists will be selected for the ROI Outstanding Article Award and receive a $5,000 research grant to continue investigations related to the published paper. We invite full-length articles addressing:
The submission deadline is March 15, 2017. Submit today at http://ees.elsevier.com/advancesradonc/default.asp
under the article type “ROI Value of RT Special Issue.”
Articles should follow the word limits and other criteria for articles established in the Guide
for Authors. More information on the ROI and how the articles will be selected for inclusion in the sponsored theme issue is available on the ROI website.